Proteomic analysis of serum cytokine levels in response to highly active antiretroviral therapy (HAART)

被引：14
|
作者：
Relucio, KI
Beernink, HT
Chen, D
Israelski, DM
Kim, R
Holodniy, M
机构：
[1] Stanford Univ, Div Infect Dis & Geog Med, Stanford, CA USA
[2] Zyomyx Inc, Hayward, CA USA
[3] San Mateo Clin Trials & Res Unit, San Mateo, CA USA
[4] Vet Affairs Palo Alto Hlth Care Syst, AIDS Res Ctr, Palo Alto, CA USA
来源：
JOURNAL OF PROTEOME RESEARCH | 2005年 / 4卷 / 02期
关键词：
HIV; HAART; cytokines; antiretroviral therapy; proteomic chip; protein microarray; MIG; IP-10; CXCL9; CXCL10;
D O I：
10.1021/pr049930y
中图分类号：
Q5 [生物化学];
学科分类号：
071010 ; 081704 ;
摘要：
A 30-cytokine protein microarray was used to screen for cytokine profile changes in HIV-infected patients in response to highly active antiretroviral therapy (HAART). Serum cytokines showing significant changes were confirmed by enzyme immunoassay. Monokine induced by gamma-interferon (MIG) and interferon-inducible protein-10 (IP-10) levels significantly decreased after 24 weeks of HAART. Protein microarrays are useful for initial screening of novel cytokine expression. Further studies are needed to elucidate the role of MIG and IP-10 in response to HAART.
引用
收藏
页码：227 / 231
页数：5
相关论文
共 50 条
  • [21] Effects of highly active antiretroviral therapy (HAART) on psychomotor performance in children with HIV disease
    Sanneke Koekkoek
    Laura Eggermont
    Leo De Sonneville
    Thidakat Jupimai
    Saijai Wicharuk
    Wichitea Apateerapong
    Theshinee Chuenyam
    Joep Lange
    Ferdinand Wit
    Chitsanu Pancharoen
    Praphan Phanuphak
    Jintanat Ananworanich
    Journal of Neurology, 2006, 253 : 1615 - 1624
  • [22] Mycobacterium xenopi osteomyelitis in a patient on highly active antiretroviral therapy (HAART)
    Kulasegaram, R
    Richardson, D
    Macrae, B
    de Ruiter, A
    INTERNATIONAL JOURNAL OF STD & AIDS, 2001, 12 (06) : 404 - 406
  • [23] Patients and family care givers' experiences around highly active antiretroviral therapy (HAART)
    Sacajiu, G.
    Raveis, V. H.
    Selwyn, P.
    AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV, 2009, 21 (12): : 1528 - 1536
  • [24] Meningiomatosis in an AIDS Patient Receiving Highly Active Antiretroviral Therapy (HAART)
    Romero, Cesar F.
    Soto-Hernandez, Jose L.
    Bonnet, Cecilia
    Cardenas, Graciela
    NEUROLOGIST, 2016, 21 (03) : 44 - 46
  • [25] The Potential of Spirulina platensis to Ameliorate the Adverse Effects of Highly Active Antiretroviral Therapy (HAART)
    Sibiya, Thabani
    Ghazi, Terisha
    Chuturgoon, Anil
    NUTRIENTS, 2022, 14 (15)
  • [26] Once-Daily Highly Active Antiretroviral Therapy (HAART). Present or future?
    Pulido, F
    Hernando, A
    MEDICINA CLINICA, 2003, 121 (08): : 304 - 309
  • [27] Predictors of use of highly active antiretroviral therapy (HAART) among persons with AIDS in San Francisco, 1996-1999
    Hsu, LC
    Vittinghoff, E
    Katz, MH
    Schwarcz, SK
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2001, 28 (04) : 345 - 350
  • [28] Changes in body habitus and serum lipid abnormalities in HIV-positive women on highly active antiretroviral therapy (HAART)
    Dong, KL
    Bausserman, LL
    Flynn, MM
    Dickinson, BP
    Flanigan, TP
    Mileno, MD
    Tashima, KT
    Carpenter, CCJ
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 1999, 21 (02) : 107 - 113
  • [29] The Effectiveness of an Antiretroviral Treatment (ARV) and a Highly Active Antiretroviral Therapy (HAART) on HIV/AIDS Epidemic Model
    Habibah, Ummu
    Sari, Ririt Andria
    8TH ANNUAL BASIC SCIENCE INTERNATIONAL CONFERENCE: COVERAGE OF BASIC SCIENCES TOWARD THE WORLD'S SUSTAINABILITY CHALLANGES, 2018, 2021
  • [30] Oral manifestations of HIV infection in patients receiving highly active antiretroviral therapy (HAART) in Bahia, Brazil
    Lima da Silva, Carlos Alberto
    Dourado, Ines
    Dahia, Samir Resack
    Harzheim, Erno
    Rutherford, George Williams
    JOURNAL OF PUBLIC HEALTH DENTISTRY, 2008, 68 (03) : 178 - 181
12345